Parameters | Categories of HbA1c | |||||||
---|---|---|---|---|---|---|---|---|
HbA1c<5.7% | HbA1c≥5.7% | |||||||
ILG (n=61) | UCG (m=56) | ILG (n=84) | UCG (n=93) | |||||
1 year | End of trial | 1 year | End of trial | 1 year | End of trial | 1 year | End of trial | |
Weight (kg) | −1.4±2.2 | −1.1±3.3 | −0.5±2.4 | −0.6±2.8 | −1.7±2.7 | −1.3±2.7 | −0.9±2.5 | −0.7±2.6 |
Fasting plasma glucose (mmol/L) | −0.1±0.5 | −0.1±0.5 | −0.0±0.5 | −0.1±0.6 | −0.1±0.5 | 0.20±0.7 | −0.1±0.6 | 0.2±1.1 |
2 h plasma glucose (mmol/L) | −1.2±1.9 | −1.2±1.9 | −1.3±1.6 | −1.2±2.0 | −1.1±2.1* | −0.17±2.5 | −0.4±2.0 | 0.1±2.8 |
Glucose AUC during OGTT | −87.3±124.3 | −76.2±123.9 | −74.7±100.3 | −78.5±136.4 | −74.9±140.0* | 1.8±176.9 | −28.9±137.7 | 18.3±206.4 |
HbA1c (%) | 0.09±0.2 | −0.07±0.3 | −0.12±0.1 | −0.00±0.3 | −0.07±0.2 | −0.02±0.3 | −0.01±0.2 | −0.08±0.4 |
Data are mean±SD.
*p<0.05 (vs UCG).
AUC, area under the curve; HbA1c, glycated hemoglobin; ILG, intensive lifestyle intervention group; OGTT, oral glucose tolerance test; UCG, usual care group.